Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
about
Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factorsIdentification of vaccine candidate antigens of an ESBL producing Klebsiella pneumoniae clinical strain by immunoproteome analysis.Identification and characterization of antigens as vaccine candidates against Klebsiella pneumoniae.Phagocytosis and Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils.Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.Enzyme-linked immunosorbent assay to evaluate the immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.Reinfection and relapse of recurrent bacteremia caused by Klebsiella pneumoniae in a medical center in Taiwan.Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae.Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli.Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development.Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse ModelHistoric aspects of intravenous immunoglobulin therapy.Antibody-Mediated Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils.
P2860
Q24550738-808E9BE7-6BC8-49BE-8E5E-C470647AF980Q33230146-9D0107C9-C900-4AA1-899E-E2B5B975F846Q34515317-724ADB26-C741-40FF-8597-DD1AB8D2AC58Q36816607-F02DF975-8F16-4637-9725-EF013B6DCFC7Q37013031-DA6A692D-7F3C-47B8-97D9-E102709C6C6EQ37157696-51DDD9E5-F7D7-4A5A-A85D-65C99170F19CQ38829314-27E30D77-2177-4479-AB71-6D439D71F934Q39517198-98DA1B7C-535D-4D95-82A8-DD87BD73BCA3Q40212881-E47E5595-15A4-419D-B47E-B8827C275D0BQ40647127-2BF21B21-16DE-4BDC-904B-2FACC53A8261Q42363276-3AD8B7E4-DA75-42F6-A390-0F0D5152C3EAQ47312443-66A7229A-C625-4B62-8DA3-F1AD392142F8Q52657375-A825B23C-147B-4309-9BFC-5731F6D30D40
P2860
Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Safety and immunogenicity of K ...... ysaccharide vaccine in humans.
@en
Safety and immunogenicity of K ...... ysaccharide vaccine in humans.
@nl
type
label
Safety and immunogenicity of K ...... ysaccharide vaccine in humans.
@en
Safety and immunogenicity of K ...... ysaccharide vaccine in humans.
@nl
prefLabel
Safety and immunogenicity of K ...... ysaccharide vaccine in humans.
@en
Safety and immunogenicity of K ...... ysaccharide vaccine in humans.
@nl
P2093
P356
P1476
Safety and immunogenicity of K ...... ysaccharide vaccine in humans.
@en
P2093
P304
P356
10.1093/INFDIS/151.4.665
P407
P577
1985-04-01T00:00:00Z